Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$40.27M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$5.5M$10.9M2025 · bought $0 · sold $10.9M20252026 · bought $0 · sold $6.4M2026
Total +$0.0000 bought · $17.30M sold

All filings on record

Every Form 4 transaction we track for this filer

NUVLSell
2026-07-06 · Nuvalent, Inc.
$3.71M
NUVLExercise
2026-07-06 · Nuvalent, Inc.
$567.9K
NUVLGrant
2026-01-07 · Nuvalent, Inc.
46,250
NUVLSell
2026-01-06 · Nuvalent, Inc.
$66.4K
NUVLSell
2026-01-06 · Nuvalent, Inc.
$477.4K
NUVLSell
2026-01-06 · Nuvalent, Inc.
$383.4K
NUVLSell
2026-01-05 · Nuvalent, Inc.
$131.7K
NUVLSell
2026-01-05 · Nuvalent, Inc.
$798.1K
NUVLSell
2026-01-05 · Nuvalent, Inc.
$457.8K
NUVLSell
2026-01-05 · Nuvalent, Inc.
$353.4K
NUVLExercise
2025-12-19 · Nuvalent, Inc.
$37.0K
NUVLSell
2025-10-16 · Nuvalent, Inc.
$64.8K
NUVLSell
2025-10-16 · Nuvalent, Inc.
$102.7K
NUVLSell
2025-10-16 · Nuvalent, Inc.
$1.26M
NUVLSell
2025-10-16 · Nuvalent, Inc.
$1.02M
NUVLExercise
2025-10-16 · Nuvalent, Inc.
$511.1K
NUVLSell
2025-09-15 · Nuvalent, Inc.
$168.0K
NUVLSell
2025-09-15 · Nuvalent, Inc.
$1.28M
NUVLSell
2025-09-15 · Nuvalent, Inc.
$691.9K
NUVLExercise
2025-09-15 · Nuvalent, Inc.
$511.1K
NUVLSell
2025-08-15 · Nuvalent, Inc.
$7.7K
NUVLSell
2025-08-15 · Nuvalent, Inc.
$521.6K
NUVLSell
2025-08-15 · Nuvalent, Inc.
$1.51M
NUVLExercise
2025-08-15 · Nuvalent, Inc.
$511.1K
NUVLSell
2025-07-15 · Nuvalent, Inc.
$8.8K

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.